BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 10674616)

  • 21. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
    Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
    Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retrospective analysis of 108 ductal carcinomas in situ of the breast treated by radiosurgery association].
    Fourneret P; Artignan X; De Cornulier J; Pasquier D; Panh MH; Payan R; Kolodié H; Vincent F; Fric D; Bernard P; Colona M; Bolla M
    Cancer Radiother; 2006 Dec; 10(8):550-8. PubMed ID: 16890006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
    Donker M; Litière S; Werutsky G; Julien JP; Fentiman IS; Agresti R; Rouanet P; de Lara CT; Bartelink H; Duez N; Rutgers EJ; Bijker N
    J Clin Oncol; 2013 Nov; 31(32):4054-9. PubMed ID: 24043739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mammographic, pathologic, and treatment-related factors associated with local recurrence in patients with early-stage breast cancer treated with breast conserving therapy.
    Kini VR; Vicini FA; Frazier R; Victor SJ; Wimbish K; Martinez AA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):341-6. PubMed ID: 10030259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.
    Lagios MD; Silverstein MJ
    Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ treated with breast-conserving surgery and radiotherapy: a comparison with ECOG study 5194.
    Motwani SB; Goyal S; Moran MS; Chhabra A; Haffty BG
    Cancer; 2011 Mar; 117(6):1156-62. PubMed ID: 21381008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast.
    Solin LJ; Kurtz J; Fourquet A; Amalric R; Recht A; Bornstein BA; Kuske R; Taylor M; Barrett W; Fowble B; Haffty B; Schultz DJ; Yeh IT; McCormick B; McNeese M
    J Clin Oncol; 1996 Mar; 14(3):754-63. PubMed ID: 8622021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study.
    Benitez PR; Streeter O; Vicini F; Mehta V; Quiet C; Kuske R; Hayes MK; Arthur D; Kuerer H; Freedman G; Keisch M; Dipetrillo T; Khan D; Hudes R
    Am J Surg; 2006 Oct; 192(4):427-33. PubMed ID: 16978943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of treatment efficacy, cosmesis, and toxicity using the MammoSite breast brachytherapy catheter to deliver accelerated partial-breast irradiation: the william beaumont hospital experience.
    Chao KK; Vicini FA; Wallace M; Mitchell C; Chen P; Ghilezan M; Gilbert S; Kunzman J; Benitez P; Martinez A
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):32-40. PubMed ID: 17467920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long term follow-up of women with ductal carcinoma in situ treated with breast-conserving surgery: the effect of age.
    Van Zee KJ; Liberman L; Samli B; Tran KN; McCormick B; Petrek JA; Rosen PP; Borgen PI
    Cancer; 1999 Nov; 86(9):1757-67. PubMed ID: 10547549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Updates in the treatment of ductal carcinoma in situ of the breast.
    Lebeau A; Kühn T
    Curr Opin Obstet Gynecol; 2016 Feb; 28(1):49-58. PubMed ID: 26694830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
    Fish EB; Chapman JA; Miller NA; Link MA; Fishell E; Wright B; McCready DR; Hiraki GY; Ross TM; Hanna WM; Lickley HL
    Ann Surg Oncol; 1998 Dec; 5(8):724-32. PubMed ID: 9869520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of Radiotherapy With Survival in Women Treated for Ductal Carcinoma In Situ With Lumpectomy or Mastectomy.
    Giannakeas V; Sopik V; Narod SA
    JAMA Netw Open; 2018 Aug; 1(4):e181100. PubMed ID: 30646103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conservative therapy of breast cancer in Queensland.
    Burke MF; Allison R; Tripcony L
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):295-303. PubMed ID: 7836083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.
    Goldstein NS; Kestin L; Vicini F
    Am J Surg Pathol; 2000 Aug; 24(8):1058-67. PubMed ID: 10935646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast conserving therapy in breast cancer patients presenting with nipple discharge.
    Obedian E; Haffty BG
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):137-42. PubMed ID: 10758315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.